IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-FLOfficial filing linked

Laurel Lee disclosed BUY $PFE

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$15K – $50K
Filed
2024-11-21
Trade date
2024-10-21
Disclosure lag
31 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 31 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
45 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Laurel Lee, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Market context is shown as a post-trade reference (-29.2% versus SPY); it is not a trading recommendation.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20026063 · filed 2024-11-21 · disclosed 31d after transaction

Market context

Pfizer Inc.

Sector: Healthcare

Vs SPY: -29.2%

Factual flags

  • 5 nearby same-ticker disclosures in the surrounding 30-day window.
  • Sits on committee with jurisdiction over pharma sector — traded PFE on 2024-10-21
  • 4 trades filed on 2024-11-21 (batch dump)

Member trail

Laurel Lee

U.S. House · FL-15

House Committee on the JudiciaryHouse Committee on Energy and CommerceHouse Committee on House Administration

Ticker trail

$PFE

Pfizer Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.